BOSTON SCIENTIFIC CORP 8-K

What Happened
Boston Scientific Corporation filed an 8-K on April 22, 2026 to announce its financial results for the quarter ended March 31, 2026. The company issued a press release on that date reporting its first-quarter results; that press release is furnished with the filing as Exhibit 99.1.

Key Details

• Press release announcing Q1 2026 results issued and furnished with the 8-K on April 22, 2026 (Exhibit 99.1).
• Quarter covered: three months ended March 31, 2026.
• The filing includes an Inline XBRL cover page (Exhibit 104) for interactive data tags.
• The 8-K was signed on behalf of Boston Scientific by Susan Thompson, Vice President, Chief Corporate Counsel and Assistant Secretary.

Why It Matters
This 8-K formally notifies investors that Boston Scientific has released its quarterly earnings information; investors should read the furnished press release (Exhibit 99.1) for the company’s reported revenue, earnings, segment performance, and any commentary on outlook or guidance. The Inline XBRL exhibit means key financial data is machine-readable for detailed analysis.